Kestra Medical Technologies, Ltd. (KMTS)

Revenue by Segment

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2021	Apr 30, 2020
Medical Products	95.13M	59.82M	27.81M	7.63M	-
Medical Products Growth	59.03%	115.05%	264.53%	-	-
Total	95.13M	59.82M	27.81M	7.63M	-
Total Growth	59.03%	115.05%	264.53%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Apr 30, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2021	Apr 30, 2020
United States	95.13M	59.82M	27.81M	7.63M	-
United States Growth	59.03%	115.05%	264.53%	-	-
Total	95.13M	59.82M	27.81M	7.63M	-
Total Growth	59.03%	115.05%	264.53%	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 17, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error